{
  "directed": true,
  "graph": {
    "annotation_curie": [],
    "annotation_list": {},
    "annotation_miriam": [],
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Gender": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Yojana Gadiya",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright Â© 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns"
    },
    "path": "hdac6/ma2018.bel",
    "pybel_version": "0.15.3"
  },
  "links": [
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The cumulative dose of cisplatin has been shown to effectively control tumor growth in mice [47].",
      "key": "0b9ca7a43e0224271a9579a061b024a9",
      "line": 85,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin-treated mice showed an impaired performance in the Y maze test, as evidenced by a reduction in the rate of perfect alternations (Fig. 1b), implying a decreased spatial working memory function (post-hoc test, p = 0.0086).",
      "key": "bb57c7ddc769f4928297745317f8016b",
      "line": 94,
      "relation": "decreases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "dfc3bcf574bf4813c1cc56dd293e85cc",
      "line": 146,
      "relation": "decreases",
      "source": 0,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Of note, we showed previously that ACY-1083 and ACY-1215 are equally effective in reversing cisplatin-induced peripheral neuropathy [31].",
      "key": "2b311323481f38d207221ddbdae5cd49",
      "line": 114,
      "relation": "increases",
      "source": 0,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "However, treatment with ACY-1215 in the same schedule that reversed peripheral neuropathy did not restore cognitive function (Fig. 1c) (two-way ANOVA, F (1, 20) = 0.3809, p = 0.54).",
      "key": "45afd803bbe88f0a4f9ac81fa629af92",
      "line": 126,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "No differences were detected in the total interaction time with objects (two-way ANOVA, F (1, 31) = 0.6425, p = 0.4289) (Fig. 2b), indicating that cisplatin and ACY-1083 had no effect on locomotor activity or interest in the objects..",
      "key": "a9852ce455bd42c054472cb868c1b583",
      "line": 135,
      "relation": "causesNoChange",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "91d76d59f161a9850dbe73a5b7317326",
      "line": 147,
      "relation": "decreases",
      "source": 0,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "68ad10cc28035dff5c1f729f3f622548",
      "line": 148,
      "relation": "decreases",
      "source": 0,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figure 3a shows that cisplatin treatment decreased Î±-tubulin acetylation in the brain (post-hoc test, p = 0.0408) and that this was reversed by ACY-1083 treatment (post-hoc test, p = 0.0170).",
      "key": "2e06388887e1766465ad4e913b45f532",
      "line": 163,
      "relation": "decreases",
      "source": 0,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "As shown in Fig. 3b, cisplatin did not change the protein level of HDAC6 in the brain (two-way ANOVA, F (1, 12) = 0.7129, p = 0.4150).",
      "key": "b3140e88d98c53c4d0e0e498c8cbd248",
      "line": 172,
      "relation": "causesNoChange",
      "source": 0,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figs. 4aâe, cisplatin treatment led to morphological damage to synaptosomal mitochondria, as evidenced by an increased percentage of atypical mitochondria that were swollen and/ or had abnormal cristae structure (post-hoc test, p = 0.0256).",
      "key": "ba881a6ce6105e09d84456d4fc6cb345",
      "line": 181,
      "relation": "increases",
      "source": 0,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figs. 4aâe, cisplatin treatment led to morphological damage to synaptosomal mitochondria, as evidenced by an increased percentage of atypical mitochondria that were swollen and/ or had abnormal cristae structure (post-hoc test, p = 0.0256).",
      "key": "ca723ea0a676354b602601dc5bd281c1",
      "line": 182,
      "relation": "negativeCorrelation",
      "source": 0,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "9bdbd7cfaf1630896bb0c23565ac6eae",
      "line": 208,
      "relation": "decreases",
      "source": 0,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "b56fbcbc8f854d5b352cb6c70a08f5b2",
      "line": 209,
      "relation": "decreases",
      "source": 0,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "066dd1043b2c555d34c0e1f67a185b79",
      "line": 221,
      "relation": "causesNoChange",
      "source": 0,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "a35b9fb8310a222d5a9023ffd9ccd77b",
      "line": 223,
      "relation": "causesNoChange",
      "source": 0,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "CA1 Region, Hippocampal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Dentate Gyrus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The results in Figs. 5 demonstrate that cisplatin reduced the expression of the presynaptic marker synaptophysin (post-hoc, p = 0.0005 for CA1, p < 0.0001 for DG) and the postsynaptic marker PSD95 (post-hoc, p = 0.0138 for CA1, p= 0.0065 for DG) in the CA1 and DG regions of the hippocampus.",
      "key": "72bae6a3fc0e108fd8cad7cd56836542",
      "line": 237,
      "relation": "decreases",
      "source": 0,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "CA1 Region, Hippocampal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Dentate Gyrus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The results in Figs. 5 demonstrate that cisplatin reduced the expression of the presynaptic marker synaptophysin (post-hoc, p = 0.0005 for CA1, p < 0.0001 for DG) and the postsynaptic marker PSD95 (post-hoc, p = 0.0138 for CA1, p= 0.0065 for DG) in the CA1 and DG regions of the hippocampus.",
      "key": "aa9134480185abb135ec4f8d5568aef6",
      "line": 238,
      "relation": "decreases",
      "source": 0,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "CA1 Region, Hippocampal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Dentate Gyrus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "We detected significant upregulation of tau phosphorylation with the AT8 antibody in the CA1 (post-hoc, p = 0.0003) (Figs. 6aâd) and DG (post-hoc, p = 0.0002) (Figs. 6eâh) regions of cisplatin-treated mice.",
      "key": "e209376438e612fcde839c23722a6b53",
      "line": 258,
      "relation": "increases",
      "source": 0,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "The cumulative dose of cisplatin has been shown to effectively control tumor growth in mice [47].",
      "key": "6d24318df68a8c79cf6f1c3bde4b18a1",
      "line": 85,
      "relation": "negativeCorrelation",
      "source": 18,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Treatment with 14 doses of the HDAC6 inhibitor ACY-1083 starting 3 days after completion of cisplatin treatment, completely reversed this cognitive deficit (post-hoc test, p = 0.0074) (Fig. 1b).",
      "key": "2ef4f839f628ff81cde807ecef44616b",
      "line": 104,
      "relation": "increases",
      "source": 2,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "8fea8145bfb197e049136a230abfacd6",
      "line": 150,
      "relation": "increases",
      "source": 2,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Of note, we showed previously that ACY-1083 and ACY-1215 are equally effective in reversing cisplatin-induced peripheral neuropathy [31].",
      "key": "2ba5a22ebfda38c5ddd7a43d1b6654b4",
      "line": 115,
      "relation": "decreases",
      "source": 2,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "No differences were detected in the total interaction time with objects (two-way ANOVA, F (1, 31) = 0.6425, p = 0.4289) (Fig. 2b), indicating that cisplatin and ACY-1083 had no effect on locomotor activity or interest in the objects..",
      "key": "6a70b355b70081f5b24010bf2b7f0502",
      "line": 136,
      "relation": "causesNoChange",
      "source": 2,
      "target": 5
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "134ebb1d656a0ca3de744f0c4287d837",
      "line": 149,
      "relation": "decreases",
      "source": 2,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "4d38ce2f855d1b5a9089e4cdde955b38",
      "line": 151,
      "relation": "increases",
      "source": 2,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Taken together, these findings indicate that cisplatin impaired spatial working memory, executive functioning, and problem-solving abilities in mice and, more importantly, that the brain-penetrating HDAC6 inhibitor ACY-1083 reversed these deficits.",
      "key": "2b8e4516d5b03430a722b69e87e7953e",
      "line": 152,
      "relation": "increases",
      "source": 2,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Brain",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figure 3a shows that cisplatin treatment decreased Î±-tubulin acetylation in the brain (post-hoc test, p = 0.0408) and that this was reversed by ACY-1083 treatment (post-hoc test, p = 0.0170).",
      "key": "81c446975835d30bb631512ec4aac934",
      "line": 164,
      "relation": "increases",
      "source": 2,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, these morphological changes were completely reversed by 2 weeks of ACY-1083 treatment (post-hoc test, p = 0.0060)",
      "key": "cb126f5e1a4b90aa860e915a610a73c9",
      "line": 193,
      "relation": "regulates",
      "source": 2,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, these morphological changes were completely reversed by 2 weeks of ACY-1083 treatment (post-hoc test, p = 0.0060)",
      "key": "711c88b83bcd6ca4142ec2bc890ffb4c",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 2,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "af1f93d09cbfcac6450f1b46a12092be",
      "line": 210,
      "relation": "increases",
      "source": 2,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Furthermore, cisplatin induced significant decreases in parameters measuring synaptosomal mitochondrial bioenergetics, including the maximal respiratory capacity (MRC) (post-hoc test, p = 0.0416) (Fig. 4f ) and spare respiratory capacity (SRC) (post-hoc test, p = 0.0147) (Fig. 4g). ACY-1083 treatment also restored cisplatin-induced impairment in MRC (post-hoc test, p = 0.0345) and SRC (post-hoc test, p = 0.0291) (Fig. 4f and g).",
      "key": "e8395d3c4b61fa76ccf98371fa7d0bac",
      "line": 211,
      "relation": "increases",
      "source": 2,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "5800b096c93d1063534082df605715a1",
      "line": 222,
      "relation": "causesNoChange",
      "source": 2,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Cisplatin and ACY-1083 did not affect basal respiration (two-way ANOVA, F (1, 20) = 0.6219, p = 0.4396) (Fig. 4h) or ATP-coupled respiration (two-way ANOVA, F (1, 20) = 0.02046, p = 0.8877; n = 6) (Fig. 4i).",
      "key": "112a951dee27cca83577de1af5e08e4b",
      "line": 224,
      "relation": "causesNoChange",
      "source": 2,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "CA1 Region, Hippocampal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Dentate Gyrus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Two weeks of ACY-1083 treatment normalized expression of both the presynaptic (post-hoc, p < 0.0001 for CA1, p < 0.0001 for DG) and postsynaptic markers (post-hoc, p = 0.0434 for CA1, p= 0.0275 for DG).",
      "key": "3271dd03c25a15cf3ff0b3c7c90dfe92",
      "line": 248,
      "relation": "increases",
      "source": 2,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "CA1 Region, Hippocampal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Dentate Gyrus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Two weeks of ACY-1083 treatment normalized expression of both the presynaptic (post-hoc, p < 0.0001 for CA1, p < 0.0001 for DG) and postsynaptic markers (post-hoc, p = 0.0434 for CA1, p= 0.0275 for DG).",
      "key": "efc96ab8e4b6b4439dcdc1ed8137b4bb",
      "line": 249,
      "relation": "increases",
      "source": 2,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "CA1 Region, Hippocampal",
            "namespace": "MeSHAnatomy"
          },
          {
            "identifier": "Dentate Gyrus",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, ACY-1083 treatment completely reversed tau hyperphosphorylation induced by cisplatin treatment (post-hoc, p = 0.0002 for CA1, p = 0.0013 for DG) (Fig. 6i and j).",
      "key": "3989c7b3da317e09d90e74af35b4937e",
      "line": 266,
      "relation": "decreases",
      "source": 2,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Of note, we showed previously that ACY-1083 and ACY-1215 are equally effective in reversing cisplatin-induced peripheral neuropathy [31].",
      "key": "8bc891cea950ff5bada7b2d91eff830e",
      "line": 116,
      "relation": "decreases",
      "source": 1,
      "target": 17
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "However, treatment with ACY-1215 in the same schedule that reversed peripheral neuropathy did not restore cognitive function (Fig. 1c) (two-way ANOVA, F (1, 20) = 0.3809, p = 0.54).",
      "key": "ad2f3e3395b2042f5087c60eb10b8094",
      "line": 125,
      "relation": "causesNoChange",
      "source": 1,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "However, treatment with ACY-1215 in the same schedule that reversed peripheral neuropathy did not restore cognitive function (Fig. 1c) (two-way ANOVA, F (1, 20) = 0.3809, p = 0.54).",
      "key": "cee1ae2f9b51824b05fb6b2f15e2488e",
      "line": 126,
      "relation": "negativeCorrelation",
      "source": 7,
      "target": 0
    },
    {
      "key": "dc131b359de33f7635fd7120aeffdb67",
      "relation": "hasVariant",
      "source": 14,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Figs. 4aâe, cisplatin treatment led to morphological damage to synaptosomal mitochondria, as evidenced by an increased percentage of atypical mitochondria that were swollen and/ or had abnormal cristae structure (post-hoc test, p = 0.0256).",
      "key": "75e1b822e37e576c6597a00cb4baa83b",
      "line": 182,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": [
          {
            "identifier": "High",
            "namespace": "Confidence"
          }
        ],
        "Gender": [
          {
            "identifier": "Male",
            "namespace": "Gender"
          }
        ],
        "MeSHAnatomy": [
          {
            "identifier": "Synaptosomes",
            "namespace": "MeSHAnatomy"
          }
        ],
        "Species": [
          {
            "identifier": "10090",
            "namespace": "Species"
          }
        ]
      },
      "citation": {
        "article_type": "Journal Article",
        "authors": [
          "Heijnen CJ",
          "Huo X",
          "Jarpe MB",
          "Kavelaars A",
          "Ma J"
        ],
        "date": "2018-10-01",
        "first": "Ma J",
        "identifier": "30270813",
        "journal": "Acta neuropathologica communications",
        "last": "Heijnen CJ",
        "name": "Pharmacological inhibition of HDAC6 reverses cognitive impairment and tau pathology as a result of cisplatin treatment.",
        "namespace": "pubmed",
        "pages": "103",
        "volume": "6"
      },
      "evidence": "Notably, these morphological changes were completely reversed by 2 weeks of ACY-1083 treatment (post-hoc test, p = 0.0060)",
      "key": "e1b6a35f3d2c92b2a167ac42d026989b",
      "line": 194,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 2
    },
    {
      "key": "080972dc80c9f38e1b7d1f7bc3b27b25",
      "relation": "hasVariant",
      "source": 11,
      "target": 12
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:cisplatin)",
      "concept": {
        "name": "cisplatin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c5ae2d0842cc71cd56eab17ff8638bf9"
    },
    {
      "bel": "a(PUBCHEM:53340666)",
      "concept": {
        "name": "53340666",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "e6ef205ddc0f44f5c05a490db98b7877"
    },
    {
      "bel": "a(PUBCHEM:91844718)",
      "concept": {
        "name": "91844718",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "8e0833f3ee7b7173cf68eb67e483147c"
    },
    {
      "bel": "bp(GO:\"cellular respiration\")",
      "concept": {
        "name": "cellular respiration",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ced509226a10b89fb0f158c6a90c60c2"
    },
    {
      "bel": "bp(GO:\"cristae formation\")",
      "concept": {
        "name": "cristae formation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "5dcac5ceb713375dc667085af2d5019c"
    },
    {
      "bel": "bp(GO:\"locomotory behavior\")",
      "concept": {
        "name": "locomotory behavior",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a907c571bb81593a8ebc7e0ebcbc2401"
    },
    {
      "bel": "bp(GO:\"respiratory gaseous exchange by respiratory system\")",
      "concept": {
        "name": "respiratory gaseous exchange by respiratory system",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "2303ff86236c48afd8f87392104d462d"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(MESH:\"Mitochondrial Size\")",
      "concept": {
        "name": "Mitochondrial Size",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "e5e0045a441d54c07400f9200271dc25"
    },
    {
      "bel": "p(HGNC:DLG4)",
      "concept": {
        "name": "DLG4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "082b74394486030c137352b1d3f26b92"
    },
    {
      "bel": "p(HGNC:HDAC6)",
      "concept": {
        "name": "HDAC6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8f10ead99d8970092c3980eb37bcfb3a"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7d1009217050e75d549c8c5aa83309a8"
    },
    {
      "bel": "p(HGNC:MAPT, pmod(go:0006468 ! \"protein phosphorylation\"))",
      "concept": {
        "name": "MAPT",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f12d372e20d49c261fa134ab17d23cdd",
      "variants": [
        {
          "concept": {
            "identifier": "0006468",
            "name": "protein phosphorylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:SYP)",
      "concept": {
        "name": "SYP",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "626a2f555ceb0470e910c27522d5b97c"
    },
    {
      "bel": "p(INTERPRO:\"Alpha tubulin\")",
      "concept": {
        "name": "Alpha tubulin",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "2b4985733912e25a1c639112bb278eef"
    },
    {
      "bel": "p(INTERPRO:\"Alpha tubulin\", pmod(go:0006473 ! \"protein acetylation\"))",
      "concept": {
        "name": "Alpha tubulin",
        "namespace": "INTERPRO"
      },
      "function": "Protein",
      "id": "fec3f9b792564a992850ade5171f1bd4",
      "variants": [
        {
          "concept": {
            "identifier": "0006473",
            "name": "protein acetylation",
            "namespace": "go"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "path(EFO:\"maximal oxygen uptake measurement\")",
      "concept": {
        "name": "maximal oxygen uptake measurement",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "02fe81678319ccacb6924e00a43d0493"
    },
    {
      "bel": "path(EFO:\"peripheral neuropathy\")",
      "concept": {
        "name": "peripheral neuropathy",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "073025e1cb3f021fa616912776a3ca45"
    },
    {
      "bel": "path(EFO:neoplasm)",
      "concept": {
        "name": "neoplasm",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "4b4402a88dd9ec5e0e5d3b321ce74567"
    },
    {
      "bel": "path(MESH:\"Energy Metabolism\")",
      "concept": {
        "name": "Energy Metabolism",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "266b2ade166522498effb10b3b6890c9"
    },
    {
      "bel": "path(MESH:\"Executive Function\")",
      "concept": {
        "name": "Executive Function",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "cf426453e61e2674d5e1e153c4463cd3"
    },
    {
      "bel": "path(MESH:\"Problem Solving\")",
      "concept": {
        "name": "Problem Solving",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "b1dcece6845c80b21c4b6c9164550663"
    },
    {
      "bel": "path(MESH:\"Spatial Memory\")",
      "concept": {
        "name": "Spatial Memory",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "6689b53b9c19fb722f9715d6f4df2ecc"
    }
  ]
}